Stock Ratings / Health Care / DXCM / dividends

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

DexCom Inc. (DXCM) Dividend Safety Gauge & 10-Year DRIP Compounder

$79.93 +1.67% NASDAQ • Public Delayed / 60s Snapshot

DexCom Inc. (DXCM) earns a Roarable Rating of B (Buy) with 73/100 RQD Confidence. High-quality cash engine (60% profit margin, 22% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.

ROARABLE B • BUY Cap $30.16B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERBUY • B

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw C+ · Rk B+

Each axis scored 0–20

12M PRICE TARGET CONE+6.8% Base Target

WHALE OPTIONS TUG-OF-WAR:54% Call Buyers ($2.9M)

46% PutsMax Pain: $78.00

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (10.4% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $26,896

Est. Year-10 Shareholder Yield: $484/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$11.0K

Yr 1

$12.2K

Yr 2

$13.5K

Yr 3

$14.9K

Yr 4

$16.4K

Yr 5

$18.1K

Yr 6

$20.0K

Yr 7

$22.1K

Yr 8

$24.4K

Yr 9

$26.9K

Yr 10

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher + Senior Cash-Flow & Income Strategist

Cash-Fortress Compounders: Collecting Safe Yield & Upside in DXCM & Top A-Rated Leaders

✓12-month Bull/Base/Bear fair-value walkthrough on DXCM and its top sector rival
✓The Top 5 Roarable A-Rated cash compounders with heavy executive & 13F accumulation
✓Includes free daily Morning Market Weather & signal upgrade/downgrade dispatch

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

DXCM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +38.19%📐 WEDGE COMPRESSION COIL

2026-10-30O $81.52H $85.25L $79.79C $82.29VOL 8.64M

RES: $87.89SUP: $76.97SMA50: $85.82SMA200: $74.56

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

DXCM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 DXCM Butterfly Map → + Track DXCM →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

27.8%/yr Implied 5Y Growth

vs. +15.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on DXCM today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

LLY → DXCM Analyst Hypothesis

Real-world payer claims data show clinicians co-prescribe Dexcom G7 and OTC Stelo continuous glucose monitors (CGMs) alongside GLP-1 initiation for metabolic feedback, offsetting delayed progression to basal insulin.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for DXCM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DXCM Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does DXCM pay a dividend and is it safe?

DexCom Inc. (DXCM) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: DXCM RQD Cockpit DXCM 12M Forecast DXCM Earnings & Move DXCM Dividends & DRIP DXCM Insiders & 13F DXCM Whale Options DXCM Profit Sankey DXCM News & Why